|
1
|
Balda A, Wani I, Roohi TF, Suman, Krishna
KL, Mehdi S, Nadiga AP, Makkapati M and Baig MAI: Psoriasis and
skin cancer-Is there a link? Int Immunopharmacol. 121:1104642023.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chi CC, Wu YW, Chao TH, Chen CC, Chen YJ,
Cheng HM, Chiu HY, Chiu YW, Chung WH, Hsieh TY, et al: 2022
Taiwanese Dermatological Association (TDA), Taiwanese Association
for Psoriasis and Skin Immunology (TAPSI), and Taiwan Society of
cardiology (TSOC) joint consensus recommendations for the
management of psoriatic disease with attention to cardiovascular
comorbidities. J Formos Med Assoc. 122:442–457. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Michalek IM, Loring B and John SM: A
systematic review of worldwide epidemiology of psoriasis. J Eur
Acad Dermatol Venereol. 31:205–212. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang TS, Hsieh CF and Tsai TF:
Epidemiology of psoriatic disease and current treatment patterns
from 2003 to 2013: A nationwide, population-based observational
study in Taiwan. J Dermatol Sci. 84:340–345. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kubota K, Kamijima Y, Sato T, Ooba N,
Koide D, Iizuka H and Nakagawa H: Epidemiology of psoriasis and
palmoplantar pustulosis: A nationwide study using the Japanese
national claims database. BMJ Open. 5:e0064502015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lee JY, Kang S, Park JS and Jo SJ:
Prevalence of psoriasis in Korea: A population-based
epidemiological study using the Korean National Health Insurance
Database. Ann Dermatol. 29:761–767. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ding X, Wang T, Shen Y, Wang X, Zhou C,
Tian S, Liu Y, Peng G, Zhou J, Xue S, et al: Prevalence of
psoriasis in China: A population-based study in six cities. Eur J
Dermatol. 22:663–667. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang SF, Lin MH, Chou PC, Hu SK, Shih SY,
Yu HS and Yu S: Genetics of generalized pustular psoriasis: Current
understanding and implications for future therapeutics. Genes
(Basel). 14:12972023. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lee LL, Huo AP and Chen SL: Experiences
and coping behaviors of patients with psoriasis: A qualitative
study. J Dermatolog Treat. 34:21936612023. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang CY, Wang CW, Chen CB, Chen WT, Chang
YC, Hui RC and Chung WH: Pharmacogenomics on the treatment response
in patients with psoriasis: An updated review. Int J Mol Sci.
24:73292023. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Honma M and Hayashi K: Psoriasis: Recent
progress in molecular-targeted therapies. J Dermatol. 48:761–777.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Furue M and Kadono T: Psoriasis: Behind
the scenes. J Dermatol. 43:4–8. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rendon A and Schakel K: Psoriasis
pathogenesis and treatment. Int J Mol Sci. 20:14752019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ohata C, Anezaki H, Kaneko S, Okazaki F,
Ito K, Matsuzaka Y, Kikuchi S, Koike Y, Murota H, Miyagi T, et al:
Clinical characteristics of patients with psoriasis with family
history: A multicenter observational study. J Dermatol. 50:746–752.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bayaraa B and Imafuku S: Relationship
between environmental factors, age of onset and familial history in
Japanese patients with psoriasis. J Dermatol. 45:715–718. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kaur I, Handa S and Kumar B: Natural
history of psoriasis: A study from the Indian subcontinent. J
Dermatol. 24:230–234. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kocaaga A and Kocaaga M: Psoriasis: An
Immunogenetic perspective. Glob Med Genet. 9:82–89. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Elyoussfi S, Rane SS, Eyre S and Warren
RB: TYK2 as a novel therapeutic target in psoriasis. Expert Rev
Clin Pharmacol. 16:549–558. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yarmolinsky J, Amos CI, Hung RJ, Moreno V,
Burrows K, Smith-Byrne K, Atkins JR, Brennan P; Colon Cancer Family
Registry (CCFR), Colorectal Cancer Transdisciplinary Study
(CORECT), ; et al: Association of germline TYK2 variation with lung
cancer and non-Hodgkin lymphoma risk. Int J Cancer. 151:2155–2160.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Enerback C, Sandin C, Lambert S,
Zawistowski M, Stuart PE, Verma D, Tsoi LC, Nair RP, Johnston A and
Elder JT: The psoriasis-protective TYK2 I684S variant impairs IL-12
stimulated pSTAT4 response in skin-homing CD4+ and CD8+ memory
T-cells. Sci Rep. 8:70432018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hao L, Kraft P, Berriz GF, Hynes ED, Koch
C, Korategere V Kumar P, Parpattedar SS, Steeves M, Yu W, et al:
Development of a clinical polygenic risk score assay and reporting
workflow. Nat Med. 28:1006–1013. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liao WL, Huang YN, Chang YW, Liu TY, Lu
HF, Tiao ZY, Su PH, Wang CH and Tsai FJ: Combining polygenic risk
scores and human leukocyte antigen variants for personalized risk
assessment of type 1 diabetes in the Taiwanese population. Diabetes
Obes Metab. 25:2928–2936. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Janssens ACJW: Validity of polygenic risk
scores: Are we measuring what we think we are? Hum Mol Genet.
28:R143–R150. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cross B, Turner R and Pirmohamed M:
Polygenic risk scores: An overview from bench to bedside for
personalised medicine. Front Genet. 13:10006672022. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dixon P, Keeney E, Taylor JC, Wordsworth S
and Martin RM: Can polygenic risk scores contribute to
cost-effective cancer screening? A systematic review. Genet Med.
24:1604–1617. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Byrne L and Toland AE: Polygenic risk
scores in prostate cancer risk assessment and screening. Urol Clin
North Am. 48:387–399. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lambert SA, Abraham G and Inouye M:
Towards clinical utility of polygenic risk scores. Hum Mol Genet.
28:R133–R142. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Johnson D, Wilke MAP, Lyle SM, Kowalec K,
Jorgensen A, Wright GEB and Drögemöller BI: A systematic review and
analysis of the use of polygenic scores in pharmacogenomics. Clin
Pharmacol Ther. 111:919–930. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sakaue S, Kanai M, Tanigawa Y, Karjalainen
J, Kurki M, Koshiba S, Narita A, Konuma T, Yamamoto K, Akiyama M,
et al: A cross-population atlas of genetic associations for 220
human phenotypes. Nat Genet. 53:1415–1424. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen TC, Wang TC, Yiu ZZN, Lee MS, Chen
LC, Chan KA, Griffiths CEM and Ashcroft DM; Global Psoriasis Atlas
(GPA), : Risk of serious infection and infection mortality in
patients with psoriasis: A nationwide cohort study using the Taiwan
National Health Insurance claims database. J Eur Acad Dermatol
Venereol. 38:136–144. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hsu MC, Wang CC, Huang LY, Lin CY, Lin FJ
and Toh S: Effect of ICD-9-CM to ICD-10-CM coding system transition
on identification of common conditions: An interrupted time series
analysis. Pharmacoepidemiol Drug Saf. 30:1653–1674. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Huang YH, Tang CH, Goh CH, Chang CL, Qiu
H, Yang YW, Saadoun C, Chang CL and Liu Y: Persistence and
adherence to biologics in patients with psoriasis in Taiwan: A new
biologics user cohort study. Front Pharmacol. 13:8809852022.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wei JC, Shi LH, Huang JY, Wu XF, Wu R and
Chiou JY: Epidemiology and medication pattern change of psoriatic
diseases in Taiwan from 2000 to 2013: A nationwide,
population-based cohort study. J Rheumatol. 45:385–392. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lee WC, Wang LY and Cheng KF: An
easy-to-implement approach for analyzing case-control and case-only
studies assuming gene-environment independence and Hardy-Weinberg
equilibrium. Stat Med. 29:2557–2567. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chiou JS, Cheng CF, Liang WM, Chou CH,
Wang CH, Lin WD, Chiu ML, Cheng WC, Lin CW, Lin TH, et al: Your
height affects your health: genetic determinants and health-related
outcomes in Taiwan. BMC Med. 20:2502022. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Genomes Project Consortium, . Auton A,
Brooks LD, Durbin RM, Garrison EP, Kang HM, Korbel JO, Marchini JL,
McCarthy S, McVean GA and Abecasis GR: A global reference for human
genetic variation. Nature. 526:68–74. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lu HF, Chou CH, Lin YJ, Uchiyama S, Terao
C, Wang YW, Yang JS, Liu TY, Wong HS, Chen SC and Tsai FJ: The
genome-wide association study of serum IgE levels demonstrated a
shared genetic background in allergic diseases. Clin Immunol.
260:1098972024. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liu TY, Lin CF, Wu HT, Wu YL, Chen YC,
Liao CC, Chou YP, Chao D, Chang YS, Lu HF, et al: Comparison of
multiple imputation algorithms and verification using whole-genome
sequencing in the CMUH genetic biobank. Biomedicine (Taipei).
11:57–65. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yang JS, Liu TY, Chen YC, Tsai SC, Chiu
YJ, Liao CC and Tsai FJ: Genome-Wide association study of alopecia
areata in Taiwan: The conflict between individuals and hair
follicles. Clin Cosmet Investig Dermatol. 16:2597–2612. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wu CY, Hu HY, Li CP, Chou YJ and Chang YT:
Comorbidity profiles of psoriasis in Taiwan: A latent class
analysis. PLoS One. 13:e01925372018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Cheng YD, Lu CC, Hsu YM, Tsai FJ, Bau DT,
Tsai SC, Cheng CC, Lin JJ, Huang YY, Juan YN, et al: In Silico and
In Vitro studies of Taiwan Chingguan Yihau (NRICM101) on
TNF-α/IL-1β-induced human lung cells. Biomedicine (Taipei).
12:56–71. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yang JS, Kang CY, Su CH, Chen CJ, Chiu YJ
and Hsu YM: Helicobacter pylori Targets in AGS Human gastric
adenocarcinoma: In situ proteomic profiling and systematic
analysis. Anticancer Res. 42:531–546. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Liao WL, Liu TY, Cheng CF, Chou YP, Wang
TY, Chang YW, Chen SY and Tsai FJ: Analysis of HLA variants and
graves' disease and its comorbidities using a high resolution
imputation system to examine electronic medical health records.
Front Endocrinol (Lausanne). 13:8426732022. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Liu TY, Liao WL, Wang TY, Chan CJ, Chang
JG, Chen YC, Lu HF, Yang HH, Chen SY and Tsai FJ: Genome-wide
association study of hyperthyroidism based on electronic medical
record from Taiwan. Front Med (Lausanne). 9:8306212022. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Willer CJ, Li Y and Abecasis GR: METAL:
Fast and efficient meta-analysis of genomewide association scans.
Bioinformatics. 26:2190–2191. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chiu HY, Tsai SC, Tsai FJ, Lo YH, Cheng
CC, Liu TY, Jhan SR, Yang JS and Chiu YJ: Liraglutide With
Metformin Therapy Ameliorates Hepatic Steatosis and Liver Injury in
a Mouse Model of Non-alcoholic Steatohepatitis. In Vivo.
37:1037–1046. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Takenaka S, Itoh T and Fujiwara R:
Expression pattern of human ATP-binding cassette transporters in
skin. Pharmacol Res Perspect. 1:e000052013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Amagai R, Takahashi T, Terui H, Fujimura
T, Yamasaki K, Aiba S and Asano Y: The antimicrobial peptide
cathelicidin exerts immunomodulatory effects via scavenger
receptors. Int J Mol Sci. 24:8752023. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Orsmark C, Skoog T, Jeskanen L, Kere J and
Saarialho-Kere U: Expression of allograft inflammatory factor-1 in
inflammatory skin disorders. Acta Derm Venereol. 87:223–227. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zhang F, Han L, Wang B, Huang Q, Yawalkar
N, Zhang Z and Yan K: Annexin A6 polymorphism is associated with
pro-atherogenic lipid profiles and with the downregulation of
methotrexate on anti-atherogenic lipid profiles in psoriasis. J
Clin Med. 11:70792022. View Article : Google Scholar
|
|
51
|
Slivka PF, Hsieh CL, Lipovsky A, Pratt SD,
Locklear J, Namovic MT, McDonald HA, Wetter J, Edelmayer R, Hu M,
et al: Small molecule and pooled CRISPR Screens Investigating IL17
Signaling Identify BRD2 as a novel contributor to keratinocyte
inflammatory responses. ACS Chem Biol. 14:857–872. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Nakagawa H, Akazaki S, Asahina A, Tokunaga
K, Matsuki K, Kuwata S, Ishibashi Y and Juji T: Study of HLA class
I, class II and complement genes (C2, C4A, C4B and BF) in Japanese
psoriatics and analysis of a newly-found high-risk haplotype by
pulsed field gel electrophoresis. Arch Dermatol Res. 283:281–284.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Abbas Zadeh S, Mlitz V, Lachner J, Golabi
B, Mildner M, Pammer J, Tschachler E and Eckhart L: Phylogenetic
profiling and gene expression studies implicate a primary role of
PSORS1C2 in terminal differentiation of keratinocytes. Exp
Dermatol. 26:352–358. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Sanchez F, Holm SJ, Mallbris L, O'Brien KP
and Stahle M: STG does not associate with psoriasis in the Swedish
population. Exp Dermatol. 13:413–418. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Acevedo F and Hammar H: Complement C3
proteins in psoriasis. Br J Dermatol. 121:329–335. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Fuentelsaz-Romero S, Cuervo A,
Estrada-Capetillo L, Celis R, García-Campos R, Ramírez J, Sastre S,
Samaniego R, Puig-Kröger A and Cañete JD: GM-CSF expression and
macrophage polarization in joints of undifferentiated arthritis
patients evolving to rheumatoid arthritis or psoriatic arthritis.
Front Immunol. 11:6139752021. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Nair RP, Stuart PE, Nistor I, Hiremagalore
R, Chia NVC, Jenisch S, Weichenthal M, Abecasis GR, Lim HW,
Christophers E, et al: Sequence and haplotype analysis supports
HLA-C as the psoriasis susceptibility 1 gene. Am J Hum Genet.
78:827–851. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
58
|
Knight J, Spain SL, Capon F, Hayday A,
Nestle FO, Clop A; Wellcome Trust Case Control Consortium; Genetic
Analysis of Psoriasis Consortium; I-chip for Psoriasis Consortium;
Barker JN, ; et al: Conditional analysis identifies three novel
major histocompatibility complex loci associated with psoriasis.
Hum Mol Genet. 21:5185–5192. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Rajesh D, Nagraj S, Kumar KSP, Kutty AVM
and Balakrishna S: Evaluation of HCP5 and Chemokine C Receptor type
5 gene polymorphisms in indian psoriatic patients. Indian J
Dermatol. 64:182–186. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Li XL, Yu H and Wu GS: Investigating the
genetic association of HCP5, SPATA2, TNIP1, TNFAIP3 and COG6 with
psoriasis in Chinese population. Int J Immunogenet. 41:503–507.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Massy E, Pedini P, Pollet E, Martin M,
Roudier J, Picard C and Balandraud N: Association study between
HLA-A, -B, -C, -DRB1 alleles and Psoriatic arthritis in southern
France. Hum Immunol. 83:515–520. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Cassia FF, Cardoso JF, Porto LC,
Ramos-E-Silva M and Carneiro S: Association of HLA Alleles and HLA
haplotypes with psoriasis, psoriatic arthritis and disease severity
in a miscegenated population. Psoriasis (Auckl). 11:41–51.
2021.PubMed/NCBI
|
|
63
|
Crivellato E and Zacchi T: The HLA system
and psoriasis: A family study. G Ital Dermatol Venereol.
120:247–254. 1985.(In Italian). PubMed/NCBI
|
|
64
|
Pyo CW, Hur SS, Kim YK, Kim TY and Kim TG:
Association of TAP and HLA-DM genes with psoriasis in Koreans. J
Invest Dermatol. 120:616–622. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Zhou X, He Y, Kuang Y, Chen W and Zhu W:
HLA-DQA1 and DQB1 alleles are associated with acitretin response in
patients with psoriasis. Front Biosci (Landmark Ed). 27:2662022.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Zhu KJ, Lv YM, Yin XY, Wang ZX, Sun LD, He
SM, Cheng H, Hu DY, Zhang Z, Li Y, et al: Psoriasis regression
analysis of MHC loci identifies shared genetic variants with
vitiligo. PLoS One. 6:e230892011. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Shawkatova I, Javor J, Parnicka Z, Kozub
P, Zilínková M, Frey P, Ferenčík S and Buc M: HLA-C, DRB1 and DQB1
alleles involved in genetic predisposition to psoriasis vulgaris in
the Slovak population. Folia Microbiol (Praha). 58:319–324. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Patel F, Marusina AI, Duong C, Adamopoulos
IE and Maverakis E: NKG2C, HLA-E and their association with
psoriasis. Exp Dermatol. 22:797–799. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Tamiya G, Shiina T, Oka A, Tomizawa M, Ota
M, Katsuyama Y, Yoshitome M, Makino S, Kimura M and Inoko H: New
polymorphic microsatellite markers in the human MHC class I region.
Tissue Antigens. 54:221–228. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Aractingi S, Briand N, Le Danff C, Viguier
M, Bachelez H, Michel L, Dubertret L and Carosella ED: HLA-G and NK
receptor are expressed in psoriatic skin: A possible pathway for
regulating infiltrating T cells? Am J Pathol. 159:71–77. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Lamore SD and Wondrak GT: Zinc pyrithione
impairs zinc homeostasis and upregulates stress response gene
expression in reconstructed human epidermis. Biometals. 24:875–890.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Vincken NLA, Welsing PMJ, Silva-Cardoso
SC, Bekker CPJ, Lopes AP, Olde Nordkamp M, Leijten EFA, Radstake
TRDJ and Angiolilli C: Suppression of IL-12/IL-23 p40 subunit in
the skin and blood of psoriasis patients by Tofacitinib is
dependent on active interferon-ү signaling in dendritic cells:
Implications for the treatment of psoriasis and interferon-driven
diseases. Exp Dermatol. 31:962–969. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Bojko A, Ostasz R, Bialecka M, Klimowicz
A, Malinowski D, Budawski R, Bojko P, Droździk M and Kurzawski M:
IL12B, IL23A, IL23R and HLA-C*06 genetic variants in psoriasis
susceptibility and response to treatment. Hum Immunol. 79:213–217.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Woo J and Lee C: Identification of
functional haplotypes in the promoter region of the LST1 gene.
Biochem Genet. 52:365–371. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Morelli M, Galluzzo M, Scarponi C, Madonna
S, Scaglione GL, Girolomoni G, Talamonti M, Bianchi L and Albanesi
C: Allelic Variants of HLA-C Upstream Region, PSORS1C3, MICA, TNFA
and genes involved in epidermal homeostasis and barrier function
influence the clinical response to Anti-IL-12/IL-23 treatment of
patients with psoriasis. Vaccines (Basel). 10:19772022. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Morelli M, Galluzzo M, Madonna S, Scarponi
C, Scaglione GL, Galluccio T, Andreani M, Pallotta S, Girolomoni G,
Bianchi L, et al: HLA-Cw6 and other HLA-C alleles, as well as
MICB-DT, DDX58, and TYK2 genetic variants associate with optimal
response to anti-IL-17A treatment in patients with psoriasis.
Expert Opin Biol Ther. 21:259–270. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Lommers E, Depierreux F, Hansen I, Dive D
and Maquet P: NMOSD with anti-MOG antibodies following anti-TNFα
therapy: A case report. Mult Scler Relat Disord. 26:37–39. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Setsirichok D, Tienboon P, Jaroonruang N,
Kittichaijaroen S, Wongseree W, Piroonratana T, Usavanarong T,
Limwongse C, Aporntewan C, Phadoongsidhi M and Chaiyaratana N: An
omnibus permutation test on ensembles of two-locus analyses can
detect pure epistasis and genetic heterogeneity in genome-wide
association studies. Springerplus. 2:2302013. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Wu X, Dong H, Luo L, Zhu Y, Peng G,
Reveille JD and Xiong M: A novel statistic for genome-wide
interaction analysis. PLoS Genet. 6:e10011312010. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Frew JW: The contradictory inefficacy of
methotrexate in hidradenitis suppurativa: A need to revise
pathogenesis or acknowledge disease heterogeneity? J Dermatolog
Treat. 31:422–423. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Cai M, Huang H, Hu Z, Yuan T, Li W, Liu Y,
Zheng L, Zhang Y, Sheng Y and Zhang X: Two variants in the NOTCH4
and HLA-C genes contribute to familial clustering of psoriasis. Int
J Genomics. 2020:69073782020. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Michailidis C, Karpouzis A, Kourmouli N,
Tripsianis G, Diplas A and Veletza S: Notch2, notch4 gene
polymorphisms in psoriasis vulgaris. Eur J Dermatol. 23:146–153.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Gao W, Sweeney C, Walsh C, Rooney P,
McCormick J, Veale DJ and Fearon U: Notch signalling pathways
mediate synovial angiogenesis in response to vascular endothelial
growth factor and angiopoietin 2. Ann Rheum Dis. 72:1080–1088.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Mehta K, Jaiswal P, Briggs F, Faubion WA,
Tabibian JH, Cominelli F and Dave M: In-patient outcomes of
hematopoietic stem cell transplantation in patients with immune
mediated inflammatory diseases: A nationwide study. Sci Rep.
8:68252018. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Chang YT, Liu HN, Shiao YM, Lin MW, Lee
DD, Liu MT, Wang WJ, Wu S, Lai CY and Tsai SF: A study of PSORS1C1
gene polymorphisms in Chinese patients with psoriasis. Br J
Dermatol. 153:90–96. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Skibola CF, Bracci PM, Halperin E, Conde
L, Craig DW, Agana L, Iyadurai K, Becker N, Brooks-Wilson A, Curry
JD, et al: Genetic variants at 6p21.33 are associated with
susceptibility to follicular lymphoma. Nat Genet. 41:873–875. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Rahman P, Roslin NM, Pellett FJ, Lemire M,
Greenwood CM, Beyene J, Pope A, Peddle L, Paterson AD, Uddin M and
Gladman DD: High resolution mapping in the major histocompatibility
complex region identifies multiple independent novel loci for
psoriatic arthritis. Ann Rheum Dis. 70:690–694. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Gregory AP, Dendrou CA, Attfield KE,
Haghikia A, Xifara DK, Butter F, Poschmann G, Kaur G, Lambert L,
Leach OA, et al: TNF receptor 1 genetic risk mirrors outcome of
anti-TNF therapy in multiple sclerosis. Nature. 488:508–511. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Nair RP, Duffin KC, Helms C, Ding J,
Stuart PE, Goldgar D, Gudjonsson JE, Li Y, Tejasvi T, Feng BJ, et
al: Genome-wide scan reveals association of psoriasis with IL-23
and NF-kappaB pathways. Nat Genet. 41:199–204. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Witoelar A, Jansen IE, Wang Y, Desikan RS,
Gibbs JR, Blauwendraat C, Thompson WK, Hernandez DG, Djurovic S,
Schork AJ, et al: Genome-wide Pleiotropy Between Parkinson Disease
and Autoimmune Diseases. JAMA Neurol. 74:780–792. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Roy M, Singh K, Shinde A, Singh J, Mane M,
Bedekar S, Tailor Y, Gohel D, Vasiyani H, Currim F and Singh R:
TNF-α-induced E3 ligase, TRIM15 inhibits TNF-alpha-regulated NF-κB
pathway by promoting turnover of K63 linked ubiquitination of TAK1.
Cell Signal. 91:1102102022. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Miao X, Xiang Y, Mao W, Chen Y, Li Q and
Fan B: TRIM27 promotes IL-6-induced proliferation and inflammation
factor production by activating STAT3 signaling in HaCaT cells. Am
J Physiol Cell Physiol. 318:C272–C281. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
He P, Cao RR, Deng FY and Lei SF:
Identification of potential pleiotropic genes for immune and
skeletal diseases using multivariate MetaCCA analysis. Curr
Genomics. 22:596–606. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Burkhart JG, Wu G, Song X, Raimondi F,
McWeeney S, Wong MH and Deng Y: Biology-inspired graph neural
network encodes reactome and reveals biochemical reactions of
disease. Patterns (NY). 4:1007582023. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Zhen Q, Yang Z, Wang W, Li B, Bai M, Wu J,
Ge H, Dong Z, Shen J, Tang H, et al: Genetic study on small
insertions and deletions in psoriasis reveals a role in complex
human diseases. J Invest Dermatol. 139:2302–2312 e14. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Gupta R, Debbaneh MG and Liao W: Genetic
epidemiology of psoriasis. Curr Dermatol Rep. 3:61–78. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Oh SM, Kim SK, Ahn HJ and Jeong KH: A
pilot genome-wide association study identifies novel markers of
metabolic syndrome in patients with psoriasis. Ann Dermatol.
35:285–292. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Chen W, Wang W, Yong L, Zhen Q, Yu Y, Ge
H, Mao Y, Cao L, Zhang R, Hu X, et al: Genome-wide meta-analysis
identifies ten new psoriasis susceptibility loci in the Chinese
population. J Genet Genomics. 49:177–180. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Connell WT, Hong J and Liao W: Genome-Wide
association study of ustekinumab response in psoriasis. Front
Immunol. 12:8151212022. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Ren Y, Wang L, Dai H, Qiu G, Liu J, Yu D,
Liu J, Lyu CZ, Liu L and Zheng M: Genome-wide association analysis
of anti-TNF-α treatment response in Chinese patients with
psoriasis. Front Pharmacol. 13:9689352022. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Kisielnicka A, Sobalska-Kwapis M,
Purzycka-Bohdan D, Nedoszytko B, Zabłotna M, Seweryn M, Strapagiel
D, Nowicki RJ, Reich A, Samotij D, et al: The analysis of a
genome-wide association study (GWAS) of overweight and obesity in
psoriasis. Int J Mol Sci. 23:73962022. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Huang YH, See LC, Chang YC, Chung WH,
Chang LC, Yang SF and Su SC: Impact of ABCG2 gene polymorphism on
the predisposition to psoriasis. Genes (Basel). 12:16012021.
View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Chang YC, Wu WM, Huang YH, Chung WH, Tsai
HY and Hsu LA: The (CCTTT) n pentanucleotide repeat polymorphism in
the inducible nitric oxide synthase gene promoter and the risk of
psoriasis in Taiwanese. Arch Dermatol Res. 307:425–432. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Chandran V and Raychaudhuri SP:
Geoepidemiology and environmental factors of psoriasis and
psoriatic arthritis. J Autoimmun. 34:J314–J321. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Elder JT, Bruce AT, Gudjonsson JE,
Johnston A, Stuart PE, Tejasvi T, Voorhees JJ, Abecasis GR and Nair
RP: Molecular dissection of psoriasis: Integrating genetics and
biology. J Invest Dermatol. 130:1213–1226. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Sanchez-Mazas A: A review of HLA allele
and SNP associations with highly prevalent infectious diseases in
human populations. Swiss Med Wkly. 150:W202142020.PubMed/NCBI
|
|
107
|
Buhler S and Sanchez-Mazas A: HLA DNA
sequence variation among human populations: Molecular signatures of
demographic and selective events. PLoS One. 6:e146432011.
View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Melief CJ and Kast WM: Cytotoxic T
lymphocyte therapy of cancer and tumor escape mechanisms. Semin
Cancer Biol. 2:347–354. 1991.PubMed/NCBI
|
|
109
|
Neefjes J, Jongsma ML, Paul P and Bakke O:
Towards a systems understanding of MHC class I and MHC class II
antigen presentation. Nat Rev Immunol. 11:823–836. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Rock KL, Reits E and Neefjes J: Present
Yourself! By MHC Class I and MHC Class II Molecules. Trends
Immunol. 37:724–737. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Gottlieb AB: Immunologic mechanisms in
psoriasis. J Invest Dermatol. 95 (5 Suppl):18S–19S. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Harden JL, Krueger JG and Bowcock AM: The
immunogenetics of psoriasis: A comprehensive review. J Autoimmun.
64:66–73. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Bartosinska J, Michalak-Stoma A, Kowal M,
Raczkiewicz D, Krasowska D, Chodorowska G and Giannopoulos K:
Analysis of circulating soluble programmed death 1 (PD-1),
neuropilin 1 (NRP-1) and human leukocyte antigen-G (HLA-G) in
psoriatic patients. Postepy Dermatol Alergol. 36:167–172. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Lee YH, Choi SJ, Ji JD and Song GG:
Genome-wide pathway analysis of a genome-wide association study on
psoriasis and Behcet's disease. Mol Biol Rep. 39:5953–5959. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Sokolik R, Gebura K, Iwaszko M, Świerkot
J, Korman L, Wiland P and Bogunia-Kubik K: Significance of
association of HLA-C and HLA-E with psoriatic arthritis. Hum
Immunol. 75:1188–1191. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Dand N, Duckworth M, Baudry D, Russell A,
Curtis CJ, Lee SH, Evans I, Mason KJ, Alsharqi A, Becher G, et al:
HLA-C*06:02 genotype is a predictive biomarker of biologic
treatment response in psoriasis. J Allergy Clin Immunol.
143:2120–2130. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Talamonti M, Galluzzo M, Zangrilli A,
Papoutsaki M, Egan CG, Bavetta M, Tambone S, Fargnoli MC and
Bianchi L: HLA-C*06:02 does not predispose to clinical response
following long-term adalimumab treatment in psoriatic patients: A
retrospective cohort study. Mol Diagn Ther. 21:295–301. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Stuart PE, Tejasvi T, Shaiq PA,
Kullavanijaya P, Qamar R, Raja GK, Li Y, Voorhees JJ, Abecasis GR,
Elder JT and Nair RP: A single SNP surrogate for genotyping
HLA-C*06:02 in diverse populations. J Invest Dermatol.
135:1177–1180. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Nikamo P and Stahle M: Cost-effective
HLA-Cw06:02 typing in a Caucasian population. Exp Dermatol.
21:221–223. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Chiu HY, Huang PY, Jee SH, Hu CY, Chou CT,
Chang YT, Hwang CY and Tsai TF: HLA polymorphism among Chinese
patients with chronic plaque psoriasis: subgroup analysis. Br J
Dermatol. 166:288–297. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Shen M, Lim SWD, Tan ES, Oon HH and Ren
EC: HLA correlations with clinical phenotypes and risk of metabolic
comorbidities in Singapore Chinese psoriasis patients. Mol Diagn
Ther. 23:751–760. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Cai M, Huang H, Ran D, Zheng X, Wen L, Zhu
Z, Liu L, Zhang C, Hong X, Hong J, et al: HLA-C*01:02 and
HLA-A*02:07 confer risk specific for psoriatic patients in Southern
China. J Invest Dermatol. 139:2045–2048. e42019. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Hirata J, Hirota T, Ozeki T, Kanai M, Sudo
T, Tanaka T, Hizawa N, Nakagawa H, Sato S, Mushiroda T, et al:
Variants at HLA-A, HLA-C, and HLA-DQB1 Confer Risk of Psoriasis
Vulgaris in Japanese. J Invest Dermatol. 138:542–548. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
124
|
van Vugt LJ, van den Reek JMPA, Hannink G,
Coenen MJH and de Jong EMGJ: Association of HLA-C*06:02 Status With
Differential Response to Ustekinumab in Patients With Psoriasis: A
systematic review and meta-analysis. JAMA Dermatol. 155:708–715.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Wei P, Yang Y, Liu Z, Luo Z, Tu W, Han J,
Deng Y and Yin L: Characterization of autoantigen presentation by
HLA-C*06:02 in psoriasis. J Invest Dermatol. 137:2238–2241. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Huang YW and Tsai TF: HLA-Cw1 and
psoriasis. Am J Clin Dermatol. 22:339–347. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Teng MW, Bowman EP, McElwee JJ, Smyth MJ,
Casanova JL, Cooper AM and Cua DJ: IL-12 and IL-23 cytokines: from
discovery to targeted therapies for immune-mediated inflammatory
diseases. Nat Med. 21:719–729. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Mirlekar B and Pylayeva-Gupta Y: IL-12
family cytokines in cancer and immunotherapy. Cancers (Basel).
13:1672021. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Gee K, Guzzo C, Che Mat NF, Ma W and Kumar
A: The IL-12 family of cytokines in infection, inflammation and
autoimmune disorders. Inflamm Allergy Drug Targets. 8:40–52. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Ek WE, Karlsson T, Hoglund J,
Rask-Andersen M and Johansson A: Causal effects of inflammatory
protein biomarkers on inflammatory diseases. Sci Adv.
7:eabl43592021. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Lowes MA, Russell CB, Martin DA, Towne JE
and Krueger JG: The IL-23/T17 pathogenic axis in psoriasis is
amplified by keratinocyte responses. Trends Immunol. 34:174–181.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Magyari L, Varszegi D, Sarlos P, Jaromi L,
Melegh BI, Duga B, Kisfali P, Kovesdi E, Matyas P, Szabo A, et al:
Marked differences of haplotype tagging SNP distribution, linkage,
and haplotype profile of IL23 receptor gene in Roma and Hungarian
population samples. Cytokine. 65:148–152. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Ogbodo E, Michelangeli F and Williams JHH:
Exogenous heat shock proteins HSPA1A and HSPB1 regulate TNF-α,
IL-1β and IL-10 secretion from monocytic cells. FEBS Open Bio.
13:1922–1940. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Generali E, Ceribelli A, Stazi MA and
Selmi C: Lessons learned from twins in autoimmune and chronic
inflammatory diseases. J Autoimmun. 83:51–61. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Valdimarsson H: The genetic basis of
psoriasis. Clin Dermatol. 25:563–567. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Kere J: Mapping and identifying genes for
asthma and psoriasis. Philos Trans R Soc Lond B Biol Sci.
360:1551–1561. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Feng BJ, Sun LD, Soltani-Arabshahi R,
Bowcock AM, Nair RP, Stuart P, Elder JT, Schrodi SJ, Begovich AB,
Abecasis GR, et al: Multiple Loci within the major
histocompatibility complex confer risk of psoriasis. PLoS Genet.
5:e10006062009. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Fan X, Yang S, Huang W, Wang ZM, Sun LD,
Liang YH, Gao M, Ren YQ, Zhang KY, Du WH, et al: Fine mapping of
the psoriasis susceptibility locus PSORS1 supports HLA-C as the
susceptibility gene in the Han Chinese population. PLoS Genet.
4:e10000382008. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Velastegui E, Vera E, Vanden Berghe W,
Munoz MS and Orellana-Manzano A: ‘HLA-C: Evolution, epigenetics,
and pathological implications in the major histocompatibility
complex’. Front Genet. 14:12060342023. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Bauer S, Groh V, Wu J, Steinle A, Phillips
JH, Lanier LL and Spies T: Activation of NK cells and T cells by
NKG2D, a receptor for stress-inducible MICA. Science. 285:727–729.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Kowalczyk AP and Green KJ: Structure,
function, and regulation of desmosomes. Prog Mol Biol Transl Sci.
116:95–118. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Linh NTT, Giang NH, Lien NTK, Trang BK,
Trang DT, Ngoc NT, Nghia VX, My LT, Mao CV, Hoang NH and Xuan NT:
Association of PSORS1C3, CARD14 and TLR4 genotypes and haplotypes
with psoriasis susceptibility. Genet Mol Biol. 45:e202200992022.
View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Allen MH, Ameen H, Veal C, Evans J,
Ramrakha-Jones VS, Marsland AM, Burden AD, Griffiths CE, Trembath
RC and Barker JN: The major psoriasis susceptibility locus PSORS1
is not a risk factor for late-onset psoriasis. J Invest Dermatol.
124:103–106. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Tawfik NZ, Abdallah HY, Hassan R, Hosny A,
Ghanem DE, Adel A and Atwa MA: PSORS1 locus genotyping profile in
psoriasis: A pilot case-control study. Diagnostics (Basel).
12:10352022. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Clop A, Bertoni A, Spain SL, Simpson MA,
Pullabhatla V, Tonda R, Hundhausen C, Di Meglio P, De Jong P,
Hayday AC, et al: An in-depth characterization of the major
psoriasis susceptibility locus identifies candidate susceptibility
alleles within an HLA-C enhancer element. PLoS One. 8:e716902013.
View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Wisniewski A, Matusiak L,
Szczerkowska-Dobosz A, Nowak I and Kusnierczyk P:
HLA-C*06:02-independent, gender-related association of PSORS1C3 and
PSORS1C1/CDSN single-nucleotide polymorphisms with risk and
severity of psoriasis. Mol Genet Genomics. 293:957–966. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Ameen M, Allen MH, Fisher SA, Lewis CM,
Cuthbert A, Kondeatis E, Vaughan RW, Murakami H, Nakagawa H and
Barker JN: Corneodesmosin (CDSN) gene association with psoriasis
vulgaris in Caucasian but not in Japanese populations. Clin Exp
Dermatol. 30:414–418. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Allen M, Ishida-Yamamoto A, McGrath J,
Davison S, Iizuka H, Simon M, Guerrin M, Hayday A, Vaughan R, Serre
G, et al: Corneodesmosin expression in psoriasis vulgaris differs
from normal skin and other inflammatory skin disorders. Lab Invest.
81:969–976. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Tazi Ahnini R, Camp NJ, Cork MJ, Mee JB,
Keohane SG, Duff GW and di Giovine FS: Novel genetic association
between the corneodesmosin (MHC S) gene and susceptibility to
psoriasis. Hum Mol Genet. 8:1135–1140. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Zwirner NW, Dole K and Stastny P:
Differential surface expression of MICA by endothelial cells,
fibroblasts, keratinocytes, and monocytes. Hum Immunol. 60:323–330.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Carlen L, Sakuraba K, Stahle M and Sanchez
F: HLA-C expression pattern is spatially different between
psoriasis and eczema skin lesions. J Invest Dermatol. 127:342–348.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Schon MP, Boehncke WH and Brocker EB:
Psoriasis: Clinical manifestations, pathogenesis and therapeutic
perspectives. Discov Med. 5:253–258. 2005.PubMed/NCBI
|
|
153
|
Telem DF, Israeli S, Sarig O and Sprecher
E: Inflammatory peeling skin syndrome caused a novel mutation in
CDSN. Arch Dermatol Res. 304:251–255. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Maekawa K, Nishikawa J, Kaniwa N, Sugiyama
E, Koizumi T, Kurose K, Tohkin M and Saito Y: Development of a
rapid and inexpensive assay for detecting a surrogate genetic
polymorphism of HLA-B*58:01: A partially predictive but useful
biomarker for allopurinol-related Stevens-Johnson syndrome/toxic
epidermal necrolysis in Japanese. Drug Metab Pharmacokinet.
27:447–450. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Lu HF, Liu TY, Chou YP, Chang SS, Hsieh
YW, Chang JG and Tsai FJ: Comprehensive characterization of
pharmacogenes in a Taiwanese Han population. Front Genet.
13:9486162022. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Patrick MT, Stuart PE, Zhang H, Zhao Q,
Yin X, He K, Zhou XJ, Mehta NN, Voorhees JJ, Boehnke M, et al:
Causal relationship and shared genetic loci between psoriasis and
type 2 diabetes through trans-disease meta-analysis. J Invest
Dermatol. 141:1493–1502. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Abramczyk R, Queller JN, Rachfal AW and
Schwartz SS: Diabetes and psoriasis: Different sides of the same
prism. Diabetes Metab Syndr Obes. 13:3571–3577. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Eiris N, Gonzalez-Lara L, Santos-Juanes J,
Queiro R, Coto E and Coto-Segura P: Genetic variation at IL12B,
IL23R and IL23A is associated with psoriasis severity, psoriatic
arthritis and type 2 diabetes mellitus. J Dermatol Sci. 75:167–172.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Patrick MT, Nair RP, He K, Stuart PE,
Billi AC, Zhou X, Gudjonsson JE, Oksenberg JR, Elder JT and Tsoi
LC: Shared genetic risk factors for multiple sclerosis/psoriasis
suggest involvement of interleukin-17 and janus kinase-signal
transducers and activators of transcription signaling. Ann Neurol.
94:384–397. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Tang Y, Liu W, Kong W, Zhang S and Zhu T:
Multisite chronic pain and the risk of autoimmune diseases: A
Mendelian randomization study. Front Immunol. 14:10770882023.
View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Huang J, Su B, Karhunen V, Gill D, Zuber
V, Ahola-Olli A, Palaniswamy S, Auvinen J, Herzig KH,
Keinänen-Kiukaanniemi S, et al: Inflammatory diseases, inflammatory
biomarkers, and Alzheimer disease: An observational analysis and
mendelian randomization. Neurology. 100:e568–e581. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Li C, Li X, Lin J, Cui Y and Shang H:
Psoriasis and progression of Parkinson's disease: a Mendelian
randomization study. J Eur Acad Dermatol Venereol. 36:2401–2405.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Ellinghaus D, Jostins L, Spain SL, Cortes
A, Bethune J, Han B, Park YR, Raychaudhuri S, Pouget JG, Hübenthal
M, et al: Analysis of five chronic inflammatory diseases identifies
27 new associations and highlights disease-specific patterns at
shared loci. Nat Genet. 48:510–518. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Yin X, Low HQ, Wang L, Li Y, Ellinghaus E,
Han J, Estivill X, Sun L, Zuo X, Shen C, et al: Genome-wide
meta-analysis identifies multiple novel associations and ethnic
heterogeneity of psoriasis susceptibility. Nat Commun. 6:69162015.
View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Gandhi G, Buttar BS, Albert L, Hasan Q and
Aggarwal RK: Psoriasis-associated genetic polymorphism in North
Indian population in the CCHCR1 gene and in a genomic segment
flanking the HLA-C region. Dis Markers. 31:361–370. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Chang YT, Hsu CY, Chou CT, Lin MW, Shiao
YM, Tsai CY, Yu CW, Shiue JJ, Lee YF, Huang CH, et al: The genetic
polymorphisms of POU5F1 gene are associated with psoriasis vulgaris
in Chinese. J Dermatol Sci. 46:153–156. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Chang YT, Tsai SF, Lee DD, Shiao YM, Huang
CY, Liu HN, Wang WJ and Wong CK: A study of candidate genes for
psoriasis near HLA-C in Chinese patients with psoriasis. Br J
Dermatol. 148:418–423. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Xia X, Yu H, Li Y, Liang Y, Li G and Huang
F: transcriptome analysis identifies biomarkers for the diagnosis
and management of psoriasis complicated with depression. Clin
Cosmet Investig Dermatol. 16:1287–1301. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Chantarangsu S, Mushiroda T,
Mahasirimongkol S, Kiertiburanakul S, Sungkanuparph S, Manosuthi W,
Tantisiriwat W, Charoenyingwattana A, Sura T, Takahashi A, et al:
Genome-wide association study identifies variations in 6p21.3
associated with nevirapine-induced rash. Clin Infect Dis.
53:341–348. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Sanchez FO, Linga Reddy MV, Mallbris L,
Sakuraba K, Stahle M and Alarcon-Riquelme ME: IFN-regulatory factor
5 gene variants interact with the class I MHC locus in the Swedish
psoriasis population. J Invest Dermatol. 128:1704–1709. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Tervaniemi MH, Siitonen HA, Soderhall C,
Minhas G, Vuola J, Tiala I, Sormunen R, Samuelsson L, Suomela S,
Kere J and Elomaa O: Centrosomal localization of the psoriasis
candidate gene product, CCHCR1, supports a role in cytoskeletal
organization. PLoS One. 7:e499202012. View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Ishida-Yamamoto A, Furio L, Igawa S, Honma
M, Tron E, Malan V, Murakami M and Hovnanian A: Inflammatory
peeling skin syndrome caused by homozygous genomic deletion in the
PSORS1 region encompassing the CDSN gene. Exp Dermatol. 23:60–63.
2014. View Article : Google Scholar : PubMed/NCBI
|
